Cryptococcus infection in tropical Australia

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3865-3868

  Jenney, Adam ^a,b,c   Pandithage, Kishan ^a   Fisher, Dale A ^a   Currie, Bart J ^a,c  

^a FLINDERS UNIVERSITY   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; CLINICAL ARTICLE; CRYPTOCOCCUS; CRYPTOCOCCUS BACILLISPORUS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HUMAN; LUNG INFECTION; MALE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; RURAL AREA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; AUSTRALIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS; HUMANS; MENINGITIS, CRYPTOCOCCAL; OCEANIC ANCESTRY GROUP; TROPICAL CLIMATE;

CRYPTOCOCCUS BACILLISPORUS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 3843100457     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3865-3868.2004     Document Type: Article

References (12)

1. Aberg, J. A., L. M. Mundy, and W. G. Powderly. 1999. Pulmonary cryptococcosis in patients without HIV infection. Chest 115:734-740.
2. Chen, S., T. Sorrell, G. Nimmo, B. Speed, B. Currie, D. Ellis, D. Marriott, T. Pfeifer, D. Parr, K. Byth, et al. 2000. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin. Infect. Dis. 31:499-508.
3. Chen, S. C. A., B. Currie, H. M. Campbell, D. A. Fisher, T. J. Pfeiffer, D. H. Ellis, and T. C. Sorrell. 1997. Cryptococcus neoformans var. gattii infection in Northern Australia: existence of environmental source other than known host eucalypts. Trans. R. Soc. Trop. Med. Hyg. 91:547-550.
4. Diamond, R. 2000. Cryptococcus neoformans, p. 2707. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed. Churchill Livingstone, New York, N.Y.
5. Fisher, D., J. Burrow, D. Lo, and B. Currie. 1993. Cryptococcosis neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. Aust. N. Z. J. Med. 23:678-682.
6. Halliday, C. L., T. Bui, M. Krockenberger, R. Malik, D. H. Ellis, and D. A. Carter. 1999. Presence of α and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J. Clin. Microbiol. 37:2920-2926.
7. Lo, D. 1976. Cryptococcosis in the Northern Territory. Med. J. Aust. 2:825-828.
8. Nunez, M., J. E. Peacock, Jr., and R. Chin, Jr. 2000. Pulmonary cryptococcosis in the immunocompetent host. Therapy with oral fluconazole: a report of four cases and a review of the literature. Chest 118:527-534.
9. Pfaller, M. A., J. Zhang, S. A. Messer, M. E. Brandt, R. A. Hajjeh, C. J. Jessup, M. Tumberland, E. K. Mbidde, and M. A. Ghannoum. 1999. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob. Agents Chemother. 43:169-171.
10. Powderly, W. G. 2000. Current approach to the acute management of cryptococcal infections. J. Infect. 41:18-22.
11. Roebuck, D. J., D. A. Fisher, and B. J. Currie. 1998. Cryptococcosis in HIV negative patients: findings on chest radiography. Thorax 53:554-557.
12. Saag, M. S., R. J. Graybill, R. A. Larsen, P. G. Pappas, J. R. Perfect, W. G. Powderly, J. D. Sobel, W. E. Dismukes, et al. 2000. Practice guidelines for the management of cryptococcal disease. Clin. Infect. Dis. 30:710-718